CYP2B6 and lung cancer: Furthermore, additional animal studies modulating the expression and/or activity level of nitrosamine metabolizing enzymes, such as CYP2A and CYP2B, would provide valuable insight into the biological mechanism behind our observed differences in lung cancer risk by CYP2B6 and CYP2A6 gene variants.